CD8A and rectal cancer: Different studies found an increase in CD8+ T cells expressing granzyme B, a cytotoxic effector molecule [182,183], in nCRT-treated rectal cancer compared to untreated tumors, suggesting enhanced anti-tumor immunity [82,179].